Glucose Favors Lipid Anabolic Metabolism in the Invasive Breast Cancer Cell Line MDA-MB-231.

dc.contributor.authorOcaña, Mª Carmen
dc.contributor.authorMartínez-Poveda, Beatriz
dc.contributor.authorQuesada, Ana R
dc.contributor.authorMedina, Miguel Ángel
dc.date.accessioned2025-01-07T17:28:32Z
dc.date.available2025-01-07T17:28:32Z
dc.date.issued2020-01-10
dc.description.abstractMetabolic reprogramming in tumor cells is considered one of the hallmarks of cancer. Many studies have been carried out in order to elucidate the effects of tumor cell metabolism on invasion and tumor progression. However, little is known about the immediate substrate preference in tumor cells. In this work, we wanted to study this short-time preference using the highly invasive, hormone independent breast cancer cell line MDA-MB-231. By means of Seahorse and uptake experiments, our results point to a preference for glucose. However, although both glucose and glutamine are required for tumor cell proliferation, MDA-MB-231 cells can survive two days in the absence of glucose, but not in the absence of glutamine. On the other hand, the presence of glucose increased palmitate uptake in this cell line, which accumulates in the cytosol instead of going to the plasma membrane. In order to exert this effect, glucose needs to be converted to glycerol-3 phosphate, leading to palmitate metabolism through lipid synthesis, most likely to the synthesis of triacylglycerides. The effect of glucose on the palmitate uptake was also found in other triple-negative, invasive breast cancer cell lines, but not in the non-invasive ones. The results presented in this work suggest an important and specific role of glucose in lipid biosynthesis in triple-negative breast cancer.
dc.identifier.doi10.3390/biology9010016
dc.identifier.issn2079-7737
dc.identifier.pmcPMC7168317
dc.identifier.pmid31936882
dc.identifier.pubmedURLhttps://pmc.ncbi.nlm.nih.gov/articles/PMC7168317/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/2079-7737/9/1/16/pdf?version=1579693295
dc.identifier.urihttps://hdl.handle.net/10668/28401
dc.issue.number1
dc.journal.titleBiology
dc.journal.titleabbreviationBiology (Basel)
dc.language.isoen
dc.organizationCentro Pfizer-Andalucía de Genómica e Investigación Oncológica (GENYO)
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectcancer
dc.subjectglucose metabolism
dc.subjectglutamine metabolism
dc.subjectlipid metabolism
dc.titleGlucose Favors Lipid Anabolic Metabolism in the Invasive Breast Cancer Cell Line MDA-MB-231.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number9

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
PMC7168317.pdf
Size:
2.12 MB
Format:
Adobe Portable Document Format